Sigyn Therapeutics, Inc. Quarterly Current Ratio in % from Q2 2016 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Sigyn Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q2 2016 to Q3 2024.
  • Sigyn Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 4.17 %, a 36.1% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 4.17 -2.36 -36.1% Sep 30, 2024
Q2 2024 3.65 -3.3 -47.5% Jun 30, 2024
Q1 2024 3.69 -4.57 -55.3% Mar 31, 2024
Q4 2023 6.13 -0.32 -4.96% Dec 31, 2023
Q3 2023 6.53 -8.15 -55.5% Sep 30, 2023
Q2 2023 6.95 -38.4 -84.7% Jun 30, 2023
Q1 2023 8.26 -93.5 -91.9% Mar 31, 2023
Q4 2022 6.45 -119 -94.9% Dec 31, 2022
Q3 2022 14.7 -127 -89.6% Sep 30, 2022
Q2 2022 45.3 -115 -71.7% Jun 30, 2022
Q1 2022 102 +53.6 +111% Mar 31, 2022
Q4 2021 126 +94.5 +303% Dec 31, 2021
Q3 2021 141 +109 +332% Sep 30, 2021
Q2 2021 160 +138 +628% Jun 30, 2021
Q1 2021 48.2 +27.5 +133% Mar 31, 2021
Q4 2020 31.1 +11.4 +58.1% Dec 31, 2020
Q3 2020 32.7 +17.2 +110% Sep 30, 2020
Q2 2020 22 +6.1 +38.3% Jun 30, 2020
Q1 2020 20.7 +4.46 +27.5% Mar 31, 2020
Q4 2019 19.7 +2.97 +17.8% Dec 31, 2019
Q3 2019 15.6 -1.71 -9.9% Sep 30, 2019
Q2 2019 15.9 Jun 30, 2019
Q1 2019 16.2 Mar 31, 2019
Q4 2018 16.7 Dec 31, 2018
Q3 2018 17.3 Sep 30, 2018
Q3 2016 57.2 Sep 30, 2016
Q2 2016 61.7 Jun 30, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.